Tg Therapeutics Inc Stock Ownership - Who owns Tg Therapeutics?

Insider buying vs selling

Have Tg Therapeutics Inc insiders been buying or selling?
Michael S. WeissCEO and President2023-08-11100,000$10.13
Sagar LonialDirector2023-06-2334,854$23.37
Sean A. PowerChief Financial Officer2023-06-0273,647$26.70
Yann EchelardDirector2023-01-069,000$10.64
Laurence N. CharneyDirector2023-01-0430,000$11.10

1 of 1

TGTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TGTX insiders and whales buy or sell their stock.

TGTX Shareholders

What type of owners hold Tg Therapeutics Inc stock?
Michael S. Weiss23.88%36,055,910$329.55MInsider
Vanguard Group Inc8.91%13,455,100$122.98MInstitution
Ra Capital Management LP8.37%12,629,868$115.44MInsider
Blackrock Inc6.57%9,917,463$90.65MInstitution
Lindsay A. Md Rosenwald6.27%9,462,616$86.49MInsider
Darwin Global Management Ltd6.15%9,278,439$84.80MInstitution
Biotechnologies Sasu Lfb5.04%7,614,855$69.60MInsider
Fmr LLC4.03%6,080,897$55.58MInstitution
State Street Corp3.73%5,628,186$51.44MInstitution
Joan Pons Gimbert2.62%3,959,149$36.19MInsider

1 of 3

TGTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TGTX53.30%46.70%Net SellingNet Buying
AGIO75.09%24.91%Net SellingNet Selling
BCRX82.86%17.14%Net BuyingNet Buying
RYTM88.09%11.91%Net SellingNet Selling
VRNA9.89%57.00%Net SellingNet Selling

Tg Therapeutics Stock Ownership FAQ

Who owns Tg Therapeutics?

Tg Therapeutics (NASDAQ: TGTX) is owned by 57.91% institutional shareholders, 50.74% Tg Therapeutics insiders, and 0.00% retail investors. Michael S. Weiss is the largest individual Tg Therapeutics shareholder, owning 36.06M shares representing 23.88% of the company. Michael S. Weiss's Tg Therapeutics shares are currently valued at $329.55M.

If you're new to stock investing, here's how to buy Tg Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.